Pricing Log in Create free account

Bicara Therapeutics Inc. (BCAX) vs Ceryvyn Therapeutics Ltd. - Unsponsored ADR (CYVNY)

Bicara Therapeutics Inc. and Ceryvyn Therapeutics Ltd. - Unsponsored ADR are both Biotechnology companies. Bicara Therapeutics Inc. is the larger, with a market value of $592.9M against $524.8M — 1.1× the size. Bicara Therapeutics Inc. has the higher net margin (0.00% vs −89,724.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 8 metrics below, Bicara Therapeutics Inc. leads on 4 and Ceryvyn Therapeutics Ltd. - Unsponsored ADR on 4.

Valuation

Metric BCAX CYVNY Biotechnology median
P/E n/m n/m 10.64
P/S n/m 2.37 9.59
P/B 1.29 n/m 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 759.28 9.45
Earnings yield (34.71%) (2,375.00%) (34.69%)
Free cash flow yield (22.30%) (84,379.36%) (24.02%)

Profitability

Metric BCAX CYVNY Biotechnology median
Gross margin — 0.00% 65.59%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (89,724.18%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (41.01%) 0.00% (51.96%)
Return on assets (38.38%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BCAX CYVNY Biotechnology median
Revenue growth (TTM) — — 4.59%
EPS growth (last fiscal year) 37.78% 61.59% 29.88%
Revenue growth, 5-year CAGR — (15.81%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BCAX CYVNY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.59 0.22 4.86
Net debt to EBITDA 2.67 0.31 1.01

Dividend

Metric BCAX CYVNY Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric BCAX CYVNY Biotechnology median
Market cap 592.91m 524.83m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack